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1. Introduction 
Cardiac tumors are among important group of cardiovascular diseases. Early diagnosis is 
necessary for the best management of the tumors. There are several imaging modalities 
available for cardiac tumors for diagnosis including echocardiography (transthoracic 
echocardiography, transesophageal echocardiography, 3 dimensional echocardiography) 
magnetic resonance imaging (MRI) and CT scan. However, echocardiography remains the 
best available noninvasive tool for the diagnosis of cardiac masses, while CT and MRI 
provide more information about the texture and extension of tumor.  
Echocardiography provides useful information about the size, texture, location, extension of 
tumors, hemodynamic effects on heart such as stenosis.  
Cardiac tumors can be found incidentally such as myxoma or left atrial thrombus in a 
patient with mitral stenosis. There is also different clinical presentation for cardiac masses 
such as constitutional symptoms, embolic events, fever etc.  
Two groups of tumors can involve the heart: primary and secondary tumors. Primary 
tumors are rare with a prevalence of 0.001 to 0.03 percent in autopsies (1).The majority of 
primary tumors are benign such as myxoma, the most common form of primary tumors, 
responsible for half of these tumors (2). One fourth of cardiac tumors are malignant, and 
sarcomas with primary cardiac lymphomas are the most common malignant primary 
cardiac tumors (3). 
Malignant primary cardiac tumors include: angiosarcoma, rhabdomyosarcoma, 
osteosarcoma, myxosarcoma, fibrosarcoma and synovial sarcoma. Various sarcomas and 
lymphomas are the most common primary malignant cardiac tumors (4, 5).  
Metastatic tumors are 20 to 40 times more common than primary malignant ones with 
prevalence of 6% in post-mortem autopsies in malignant diseases (6). The most common 
tumors that metastasize to heart are from lung, breast, kidney, and liver; and among tumor 
variety, lymphoma, melanoma and osteogenic sarcoma (2).  
Malignant tumors can metastasize to heart via hematogenous spread from inferior vena 
cava such as renal and hepatic tumors or via metastatic formation by systemic tumors such 
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as malignant melanoma, lymphomas, leukaemias and sarcomas. Lymphatics and direct 
invasion from adjacent organs such as lung and breast cancers or mediastinal lymphomas is 
another way of spread (7, 6). 
2. Benign primary cardiac tumors 
2.1 Myxoma 
Three quarters of all primary cardiac tumors are benign and half of them are myxomas. 
These tumors occur mostly in third decade or later. Myxomas can occur as an isolated tumor 
in left atrium (the most common site of this tumor)[figure 1] or as familial form (Carney 
syndrome) which is associated with other manifestations. Most frequently it occurs in left 
atrium, then in right atrium, right ventricle and left ventricle; it can infrequently involve the 
valves. It is mostly attached to fossa ovalis via its stalk. 
 
 
Fig. 1. Parasternal long axis view. A 38 year old man with history of dyspnea. 
Echocardiography revealed left atrial mass. He underwent cardiac surgery and pathology 
showed myxoma.  
Myxoma has different clinical presentations. These include constitutional symptoms such as 
fever, weight loss, embolic events and symptoms of valvular obstruction such as the 
symptoms of mitral valve stenosis (figure 2). 
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Fig. 2. A 38 year old man with history of dyspnea. Myxoma can protrude through mitral 
valve and in M-mode mitral stenosis can be visualized as seen in this Echocardiograph. 
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It has also different shapes as rounded or polypoid with narrow stalk and attachment to 
interatrial septum or fossa ovalis. The mass is mostly homogenous; however, small scattered 
area of calcification may be seen. Mobile particles of this tumor describe and predict its 
tendency for embolic events (8). 
Echocardiography provides useful information about the location, size, extension and 
texture of this tumor, and one should be careful not to miss the multiple myxomas that 
could be found in other chambers. 
Definite treatment for myxoma is total excision of the mass. Follow up echocardiography to 
rule out recurrence is recommended. 
2.2 Papillary fibroelastoma 
Papillary fibroelastoma is a rare, primary benign cardiac tumor that is most frequently 
found in the cardiac valves (9). It is the third primary cardiac tumor after myxoma and 
lipoma. These tumors are mostly found incidentally on post mortem. However, because of 
high tendency for systemic emboli, prompt diagnosis and management is necessary. Other 
rare presentations such as sudden death have been reported (10-12).  
Papillary fibroelastoma represents 7.9% of benign primary cardiac tumor in adults (9). 
Approximately 90% of primary fibroelastomas arise from valves on ventricular side of 
pulmonary and aortic valve and atrial side of mitral and tricuspid valve (13-14). Aortic or 
mitral valves are mostly affected (15-16). The tricuspid valve is most affected in children; 
however, mitral and aortic valves are mostly affected in adults (17). Echocardiography 
remains the main tool for detection of this tumor. Because of involvement of cardiac valves 
other diagnosis such as infective endocarditis, degenerative changes and 0Lamble’s 
excrescences should be kept in mind. Typical echocardiographic features include round, 
oval or irregular appearance, with a homogenous texture with small stalk (18). Surgical 
removal is indicated for large mobile tumors. 
2.3 Rhabdomyoma 
It is the most frequent cardiac tumor of childhood (about 60% of cardiac tumors) which is 
frequently found by fetal echocardiography (8). This tumor occurs in both ventricles equally 
with intramural involvement; however, atrioventricular valves involvement is also seen. 
This tumor may regress spontaneously. 
2.4 Lipoma 
It is a benign cardiac tumor that is asymptomatic in many patients (3). CT scan or MRI can 
easily define the tissue characteristic of fat and make an accurate diagnosis. 
2.5 Hemangioma 
It is a benign vascular tumor which occurs equally in left and right ventricles, and in right 
atrium. When tumor is resectable, total excision is recommended. Other benign cardiac 
tumors include cardiac paraganglioma (8) and fibroma. 
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3. Malignant primary cardiac tumors 
Sarcomas are the most common primary malignant tumors and consist of 95% of cases. Any 
part of heart can be affected and rapid progression of disease is the usual clinical course of 
this tumor (8). 
3.1 Angiosarcoma 
Angiosarcoma is the most common primary malignant cardiac tumor (7). Men are involved 
more than female with a ratio of 2:1. Its usual location is right atrium and interatrial septum 
with involvement of pericardium and pericardial effusion [figure 3] (8). Other forms of 
sarcoma can occur in the left side of the heart and resemble the presentation of myxoma. It 
has a poor prognosis. 
 
Fig. 3. Large tumor in right atrium with invasion toward interatrial septum and left atrium 
with pericardial effusion. In a 27 year old man who presented with progressive dyspnea. 
4. Metastatic cardiac tumors 
Metastatic tumors are 20 to 40 times more common than primary malignant ones with 
prevalence of 6% in post-mortem autopsies in malignant diseases (6). 
4.1 Malignant melanoma 
For the first time the term “melanotic heart” was introduced by William Norris in 1820 (7). 
However, many cases of malignant melanoma have been described in scientific literature. 
www.intechopen.com
 
Echocardiography – In Specific Diseases 
 
158 
Malignant melanoma frequently (50-71%) metastasizes to the heart (19). It seems to have the 
highest rate of metastases to heart. When a patient presents with cardiac metastases of 
melanoma, the disease has already spread throughout the body and is rarely curable (20). 
Single metastasis is rare. Metastases could be found in right side or left side; however, 
bilateral metastasis is frequently seen (21). The way of tumor spread toward heart is mostly 
hematogenous as seen in lymphoma and leukemia. 
Previously, histologic diagnosis of malignant melanoma was made postmortem; however, 
with early detection of metastases due to availability of new imaging modalities, definite 
antemortem diagnosis and pathologic examination is frequently possible. Tissue specimen 
can be obtained by echocardiography guided transvenous biopsy or by resection of mass 
(22). 
The symptoms are nonspecific such as chronic pericarditis, congestive heart failure, 
pericardial effusion, tamponade, conduction disturbances or defects, arrhythmias such as 
ventricular or supraventricular heart rhythm disturbances (23,24), syncope, embolism events 
such as transient ischemic attack and hemodynamic changes secondary to valve 
dysfunction. 
Malignant melanoma has the highest rate of metastases to heart; however, due to 
improvement in treatment for this disease, longer survival than previous is now possible 
(25) and with newer imaging modalities early detection of metastases is possible and the 
physician should be alert of the risk of metastases. Transesophageal echocardiography has 
higher sensitivity than transthoracic echocardiography and cardiac magnetic resonance 
imaging with its ability to define the mediastinal involvement could also be used. According 
to tumor characteristics, its burden, location and size, palliative surgery or complete 
resection or adjuvant systemic therapy is recommended. 
5. Summary 
Echocardiography both transthoracic echocardiography (TTE), transesophageal 
echocardiography (TEE), is the commonly available noninvasive method for the diagnosis of 
cardiac masses. Tumor size, location and texture, and its extension to adjacent organs, its 
attachment to cardiac structures, presence or absence of pericardial effusion, interference 
with valve function, any obstruction and tumor mobility could be evaluated by 
echocardiography. In patients with poor echo window, TEE gives superior results, however, 
in some patients for better evaluation of cardiac tumor and its extension, other imaging 
modalities such as MRI is needed. Extra cardiac structures could be visualized better in TTE 
then TEE which is important for surgeons for choosing the most suitable plan for surgery(7). 
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